莎莉美容控股公司 SBH 深 滬
等待開盤 11-15 09:30:00 美东时间
14.18
-0.270
-1.87%
華盛通- 最 高14.3599
- 今 開14.15
- 成交量 275.55万股
- 最 低 13.53
- 昨 收 14.45
- 總市值 14.03亿
- 52周最高 17.40
- 市盈率 靜 7.50
- 換手率 2.78%
- 52周最低 7.54
- 委 比 -47.37%
- 總股本 9894.48万
- 歷史最高 35.27
- 量 比 0.97
- 振 幅 5.74%
- 歷史最低 6.28
- 每 手 1
- 風險率 2.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Is A Short Squeeze Powering Sally Beauty's Sudden Double-Digit Spike?
Sally Beauty Holdings (NYSE: SBH) reported Q4 financial results, beating street estimates with 10% increase in earnings.
11-13 22:56
Sally Beauty Holdings (NYSE: SBH) Sets Three-Year Target for 1%–3% Annual Net Sales Growth Through FY2028..
Sally Beauty Holdings (NYSE:SBH) sets three-year target for 1%–3% annual net sales growth through FY2028.
11-13 20:34
Sally Beauty Reports Q4 Financial Results, EPS Rises
Sally Beauty ( ($SBH) ) has issued an update. On November 13, 2025, Sally Beaut...
11-13 20:18
Sally Beauty Holdings Q4 Adj. EPS $0.55 Beats $0.47 Estimate, Sales $947.075M Beat $932.905M Estimate
Sally Beauty Holdings (NYSE:SBH) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.47 by 15.79 percent. This is a 10 percent increase over earnings of $0.50 per share from the
11-13 19:46
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
10-29 09:25
Jefferies Maintains Hold on Sally Beauty Holdings, Raises Price Target to $14.5
Jefferies analyst Stephanie Wissink maintains Sally Beauty Holdings (NYSE:SBH) with a Hold and raises the price target from $12.8 to $14.5.
10-28 20:16
快讯 | Sally Beauty与DoorDash合作，为您送上秋季美容必备单品，让您随时随地美丽无忧
Sally Beauty and DoorDash Team up to Deliver Fall Beauty Must-Haves on the Go
09-17 21:03
美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
Canaccord Genuity Maintains Buy on Sally Beauty Holdings, Raises Price Target to $19
Canaccord Genuity analyst Susan Anderson maintains Sally Beauty Holdings (NYSE:SBH) with a Buy and raises the price target from $15 to $19.
09-15 19:44
